Holen Sie sich die Stockscreener-App
137.70
0.51%
0.70
Handel nachbörslich:
137.70
Schlusskurs vom Vortag:
$137.00
Offen:
$138.08
24-Stunden-Volumen:
493.05K
Relative Volume:
1.08
Marktkapitalisierung:
$4.19B
Einnahmen:
$560.03M
Nettoeinkommen (Verlust:
$-150.66M
KGV:
-28.33
EPS:
-4.86
Netto-Cashflow:
$-87.43M
1W Leistung:
+5.02%
1M Leistung:
+33.11%
6M Leistung:
+59.23%
1J Leistung:
+37.87%
1-Tages-Spanne:
$136.89
$139.53
1-Wochen-Bereich:
$128.76
$140.73
52-Wochen-Spanne:
$55.92
$140.73
Irhythm Technologies Inc Stock (IRTC) Company Profile
Firmenname
Irhythm Technologies Inc
Sektor
Branche
Telefon
415-632-5700
Adresse
699 8TH STREET, San Francisco, CA
Vergleichen Sie IRTC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
137.70 | 4.19B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-06-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-07 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-02-24 | Hochstufung | Needham | Hold → Buy |
| 2022-01-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-06-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-04-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Bestätigt | Needham | Hold |
| 2020-11-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Eingeleitet | Needham | Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-08-07 | Hochstufung | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-10 | Eingeleitet | William Blair | Outperform |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Perform |
| 2019-02-20 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Bestätigt | Canaccord Genuity | Buy |
| 2018-09-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-08-02 | Hochstufung | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Herabstufung | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Eingeleitet | Dougherty & Company | Neutral |
Alle ansehen
Irhythm Technologies Inc Aktie (IRTC) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iRhythm Technologies, Inc. (IRTC) - ACCESS Newswire
Investors who lost money on iRhythm Technologies, Inc. (IRTC) should contact Levi & Korsinsky about pending Class ActionIRTC - ACCESS Newswire
iRhythm (IRTC) Receives Price Target Boost from Truist Analyst | - GuruFocus
iRhythm (IRTC) Receives Price Target Boost from Truist Analyst | IRTC Stock News - GuruFocus
iRhythm Technologies (IRTC) Raises Revenue Guidance Amid Growth - GuruFocus
iRhythm Technologies (IRTC) Beats Estimates, Forecasts Robust Growth - GuruFocus
iRhythm Technologies First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q1 2025 Earnings Call Transcript - Insider Monkey
Wells Fargo Upgrades iRhythm Technologies (LSE:0A7L) - Nasdaq
iRhythm Technologies, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before April 8, 2024 to Discuss Your Rights – IRTC - ACCESS Newswire
Wells Fargo Upgrades iRhythm Technologies Stock, Raises Price Target To $130: Retail’s Thrilled - MSN
IRhythm Technologies Shares Jump After Q1 Revenue Beat - marketscreener.com
Wells Fargo Upgrades iRhythm Technologies Stock, Raises Price Target To $130: Retail’s Thrilled By Stocktwits - Investing.com India
Wells Fargo Upgrades iRhythm Technologies (BIT:1IRTC) - Nasdaq
Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts - Benzinga
IRTC: Canaccord Genuity Maintains Buy Rating but Lowers Price Target | IRTC Stock News - GuruFocus
Wells Fargo Upgrades iRhythm Technologies (IRTC) - Nasdaq
Baird Raises Price Target for iRhythm Technologies (IRTC) | IRTC Stock News - GuruFocus
This FTAI Aviation Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday - Benzinga
iRhythm stock gets a boost on Q1 results, continued momentum with Zio launch in Japan - MassDevice
IRTC Stock Boosted by Wells Fargo Upgrade and Price Target Raise | IRTC Stock News - GuruFocus
iRhythm Technologies, Inc. to Host Earnings Call - ACCESS Newswire
Baird Boosts iRhythm (IRTC) Price Target to $150, Maintains Outp - GuruFocus
Baird Boosts iRhythm (IRTC) Price Target to $150, Maintains Outperform Rating | IRTC Stock News - GuruFocus
IRTC: Needham Raises Price Target for iRhythm Technologies | IRT - GuruFocus
IRTC: Needham Raises Price Target for iRhythm Technologies | IRTC Stock News - GuruFocus
Deep Dive Into iRhythm Technologies Stock: Analyst Perspectives (5 Ratings) - Benzinga
IRTC: BTIG Ups Price Target Following Strong Sales Performance | - GuruFocus
Canaccord Adjusts Price Target for iRhythm (IRTC), Maintains Buy Rating | IRTC Stock News - GuruFocus
IRTC: BTIG Ups Price Target Following Strong Sales Performance | IRTC Stock News - GuruFocus
Wells Fargo lifts iRhythm stock rating, targets $130 By Investing.com - Investing.com India
Wells Fargo Upgrades iRhythm Technologies to Overweight, Price Target is $130 - marketscreener.com
Wells Fargo Boosts iRhythm (IRTC) with Upgraded Rating and Highe - GuruFocus
iRhythm Technologies Inc (IRTC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges - GuruFocus
Wells Fargo Boosts iRhythm (IRTC) with Upgraded Rating and Higher Target | IRTC Stock News - GuruFocus
iRhythm Technologies Inc (IRTC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... By GuruFocus - Investing.com Canada
iRhythm Technologies Reports Strong Q1 2025 Growth - TipRanks
IRhythm Technologies Q1 Adjusted Loss Narrows, Revenue Rises; 2025 Sales Guidance Raised - marketscreener.com
iRhythm Technologies Inc (IRTC) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance
iRhythm (IRTC) Expands ECG Monitoring with Japanese Launch | IRT - GuruFocus
iRhythm Technologies, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:IRTC) - Seeking Alpha
Earnings call transcript: iRhythm Technologies Q1 2025 sees stock rise after revenue beat - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Earnings call transcript: iRhythm Technologies Q1 2025 sees stock rise after revenue beat By Investing.com - Investing.com South Africa
iRhythm Q1 2025 presentation: Revenue jumps 20%, guidance raised on market expansion - Investing.com India
IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
iRhythm (NASDAQ:IRTC) Surprises With Strong Q1, Full-Year Sales Guidance is Optimistic - Yahoo Finance
iRhythm Technologies beats Q1 estimates, raises 2025 outlook; shares rise - Investing.com Australia
iRhythm Technologies beats Q1 estimates, raises 2025 outlook; shares rise By Investing.com - Investing.com South Africa
iRhythm Technologies, Inc. SEC 10-Q Report - TradingView
IRHYTHM TECHNOLOGIES Earnings Results: $IRTC Reports Quarterly Earnings - Nasdaq
Finanzdaten der Irhythm Technologies Inc-Aktie (IRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):